Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05010850 · ClinicalTrials.gov registry record · NA
SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study
A NA study, sponsored by SafeHeal.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT05010850 is a NA study that was terminated before completion, run by SafeHeal. The registered enrollment target is 18 participants.
The verdict
NCT05010850, a NA study, was terminated before completion, sponsored by SafeHeal.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
A randomized trial to assess the safety and effectiveness of the Colovac in providing temporary protection of the anastomosis in subjects undergoing lower anterior resection for colorectal cancer.
Interventions
- DEVICE Colovac
- PROCEDURE Stoma Creation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2022-01-17 |
| Est. Completion | 2024-01-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05010850
The ClinicalTrials.gov registry entry for NCT05010850 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SafeHeal, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Colovac is the first listed.
NCT05010850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05010850 about?
NCT05010850 is a clinical study titled "SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study". A randomized trial to assess the safety and effectiveness of the Colovac in providing temporary protection of the anastomosis in subjects undergoing lower anterior resection for colorectal cancer.
What is the current status of trial NCT05010850?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2022-01-17. Estimated completion is 2024-01-19.
What interventions are being tested in trial NCT05010850?
The interventions under investigation include: Colovac (DEVICE), Stoma Creation (PROCEDURE).
Who is sponsoring clinical trial NCT05010850?
This trial is sponsored by SafeHeal, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.